Insufficient scRNA-seq data for expression of FBXL14 at single-cell level.
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 478.10 | 180 / 180 | 100% | 37.55 | 430 / 430 |
esophagus | 100% | 530.94 | 1445 / 1445 | 99% | 29.80 | 182 / 183 |
brain | 100% | 728.69 | 2637 / 2642 | 99% | 23.69 | 699 / 705 |
stomach | 100% | 605.34 | 359 / 359 | 99% | 33.97 | 283 / 286 |
intestine | 100% | 718.83 | 966 / 966 | 98% | 31.57 | 519 / 527 |
pancreas | 100% | 433.56 | 328 / 328 | 98% | 20.21 | 174 / 178 |
thymus | 100% | 735.96 | 652 / 653 | 98% | 24.78 | 591 / 605 |
breast | 100% | 517.36 | 459 / 459 | 97% | 19.43 | 1084 / 1118 |
lung | 99% | 632.87 | 572 / 578 | 97% | 18.37 | 1122 / 1155 |
prostate | 100% | 422.09 | 245 / 245 | 96% | 18.95 | 481 / 502 |
skin | 100% | 395.63 | 1804 / 1809 | 96% | 21.96 | 452 / 472 |
kidney | 100% | 436.89 | 89 / 89 | 95% | 15.73 | 852 / 901 |
bladder | 100% | 477.67 | 21 / 21 | 92% | 17.57 | 465 / 504 |
uterus | 100% | 479.88 | 170 / 170 | 91% | 14.25 | 418 / 459 |
adrenal gland | 99% | 442.63 | 255 / 258 | 90% | 16.68 | 206 / 230 |
liver | 97% | 215.10 | 219 / 226 | 68% | 6.27 | 275 / 406 |
adipose | 100% | 546.47 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 665.19 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 477.42 | 1330 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 316.73 | 843 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 525.58 | 885 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 90% | 9.68 | 72 / 80 |
muscle | 89% | 195.71 | 715 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 89% | 17.39 | 40 / 45 |
lymph node | 0% | 0 | 0 / 0 | 83% | 14.30 | 24 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0031146 | Biological process | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process |
GO_0019005 | Cellular component | SCF ubiquitin ligase complex |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | FBXL14 |
Protein name | F-box/LRR-repeat protein 14 (F-box and leucine-rich repeat protein 14) |
Synonyms | FBL14 |
Description | FUNCTION: Substrate-recognition component of some SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin-protein ligase complexes. The SCF(FBXL14) complex acts by mediating ubiquitination and subsequent degradation of SNAI1. . |
Accessions | ENST00000339235.4 Q8N1E6 |